Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study

The global, randomized NAPOLI‐1 phase 3 trial reported a survival benefit with liposomal irinotecan (nal‐IRI) plus 5‐fluorouracil/leucovorin (nal‐IRI+5‐FU/LV) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) after previous gemcitabine‐based therapy. Median overall survival (OS) w...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Sci
Main Authors: Bang, Yung‐Jue, Li, Chung‐Pin, Lee, Kyung‐Hun, Chiu, Chang‐Fang, Park, Joon Oh, Shan, Yan‐Shen, Kim, Jun Suk, Chen, Jen‐Shi, Shim, Hyun‐Jeong, Rau, Kun‐Ming, Choi, Hye Jin, Oh, Do‐Youn, Belanger, Bruce, Chen, Li‐Tzong
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2019
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004519/
https://ncbi.nlm.nih.gov/pubmed/31789476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14264
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker